Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Controlled, Phase II Clinical Study of Becotatug Vedotin Combined With Pucotenlimab for Neoadjuvant and Adjuvant Treatment of Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

NCT07632339 is registered in ClinicalTrials.gov with Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University as lead sponsor.

NCT NCT07632339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Controlled, Phase II Clinical Study of Becotatug Vedotin Combined With Pucotenlimab for Neoadjuvant and Adjuvant Treatment of Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
Lead sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase
Phase 2
Overall status
Recruiting
Start date
June 16, 2026
Completion date
June 16, 2029
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer